Concepedia

Anna M. van Eggermond

AM

8

Publications

930

Citations

8

H-Index

2012

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Leiden University Medical Center

Radboud University Nijmegen

Radboud University Medical Center

University Medical Center Utrecht

Anna M. van Eggermond is an author at The Netherlands Cancer Institute specializing in obstetrics, oncology, and cancer research.

Top concepts

Publications per year

2012–2020

8

Publications

8

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 605 citations · Full text

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

Simone de Vries, Michael Schaapveld, Cécile P.M. Janus et al. · JNCI Journal of the National Cancer Institute · 2020 · 90 citations · Full text

Risk of multiple primary malignancies following treatment of Hodgkin lymphoma

Anna M. van Eggermond, Michael Schaapveld, Pieternella J. Lugtenburg et al. · Blood · 2014 · 73 citations

Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure

Inge M. Krul, Annemieke W. J. Opstal‐van Winden, Berthe M.P. Aleman et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 47 citations · Full text

, , +9

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma

Annemieke W. J. Opstal‐van Winden, Hugoline G. de Haan, Michael Hauptmann et al. · Blood · 2018 · 44 citations · Full text

Rows per page

1–5 of 8